Alcohol & coping

When prescription medication becomes a concern

Prepare for a medication review and understand why dependence and withdrawal need individual clinical advice.

Men's Midlife GuideUpdated 22 September 2026

A medicine can begin as a reasonable response to pain, panic, sleeplessness or another health problem and later become something you feel anxious about taking, changing or running out of. That deserves a careful review, not a moral judgement. Equally, using prescribed medication over a long period does not automatically mean you have an addiction.

The most useful first step is to describe exactly what is happening and arrange a medication review with the prescriber or another appropriately qualified clinician. Do not test your willpower by stopping suddenly. The plan must account for the medicine, the condition being treated and your current safety.

Dependence and addiction are not interchangeable

Physical dependence means the body has adapted to a medicine, so reducing or stopping it can cause withdrawal. It can occur with some medicines even when they are taken as prescribed. Addiction involves a different assessment of impaired control and continued use despite harm. The FDA distinguishes these issues in its benzodiazepine safety guidance. [1]

That distinction matters when discussing your concerns. “I feel unwell when I miss a dose” and “I keep taking more than agreed despite consequences” are different pieces of information. Both deserve attention; neither should be dismissed or treated as a complete diagnosis on its own.

Ask the clinician to explain the terms they use. A clear explanation is more helpful than a label that leaves you frightened about your future care.

Start with the change you have noticed

Write down the concern in practical terms. Perhaps you are taking a night-time medicine earlier, planning travel around your supply, feeling unusually drowsy, or worrying that the original treatment no longer fits. Perhaps another person has noticed something you had not recognised.

Include when the change started, what was happening around that time and how it affects your day. Note whether the issue followed a new prescription, a dose change, an illness, a bereavement or a period of heavier drinking. This is a history to discuss, not a way to identify the cause by yourself.

A useful opening is: “This treatment helped initially, but I am now concerned about these specific changes. Can we review the benefits, risks and alternatives together?”

Make the whole medication picture visible

Bring an accurate list of prescriptions, over-the-counter products, supplements and medicines obtained elsewhere. Include how you actually take them, not only the instructions on the label. An honest record is more useful than a tidy one.

Tell the clinician about alcohol and other substances. Combining benzodiazepines with opioids or alcohol can create serious safety risks, including dangerous sedation and breathing problems. [1] A pharmacist can help reconcile the list and identify questions for the prescriber, particularly when several specialists are involved.

Ask who is coordinating the overall plan. A clear lead clinician and an agreed communication process can prevent you from being left to resolve conflicting advice between appointments. Keep an updated copy of the plan somewhere accessible.

Do not create an abrupt stopping experiment

Benzodiazepine withdrawal can be dangerous, and stopping or reducing these medicines requires an individualised clinical plan. [1] CDC guidance similarly warns against abruptly discontinuing ongoing opioid therapy in the absence of a life-threatening concern and emphasises shared decisions about risks and benefits. [2]

This article cannot provide a taper schedule. A schedule copied from another person, forum or retreat brochure may be inappropriate for your medicine and circumstances. Do not substitute alcohol, someone else’s prescription or an unverified online product to manage the situation.

If you are running out, contact the prescriber or an urgent medical service promptly and explain the risk of interrupted treatment. A supply problem is something to address clinically, not conceal until the last tablet is gone.

Keep the original condition in the conversation

A medication review should not erase the reason treatment began. Ask how pain, anxiety, sleep disruption or another underlying problem will be assessed and managed while the medication plan is reviewed.

For example, someone taking a medicine for sleep might need a separate assessment of the sleep problem rather than a discussion limited to stopping tablets. Someone treated for pain may want goals expressed in everyday function: sitting through a meeting, walking comfortably or spending time with family.

Write down what the medicine still helps, what it no longer helps and what concerns you. That balanced account makes room for a plan that is neither “continue everything indefinitely” nor “remove everything immediately”. The clinical judgement should remain individual. [2]

Prepare for a review without turning it into a defence

You do not need to prove that you are a good patient. Bring prescription information, previous treatment records if available, and a short description of your current routine. NIMH recommends preparing questions and relevant health information before appointments. [3]

Useful questions include: What are the main safety concerns? Could these symptoms have more than one explanation? Which changes are being proposed, and why? Who should I contact if I struggle? What should prompt urgent help rather than waiting for the next review?

Ask for the plan in writing. If you feel pressured, confused or unheard, say so and request clarification or an appropriately qualified second opinion. Do not quietly improvise a different plan because the agreed one was unclear.

Privacy and professional responsibilities

You may worry about your reputation, work or family learning that medication has become complicated. Start by asking the service how records, correspondence, billing and emergency contacts are handled. Obtain specific answers rather than relying on the word “discreet”.

Explain any work involving driving, machinery, clinical responsibility or other safety-sensitive tasks so the clinician can advise on your circumstances. If you feel impaired, avoid the activity and seek advice rather than relying on confidence that you can compensate.

Consider what practical support would help without unnecessary disclosure. That might mean arranging transport to an appointment, reducing travel temporarily or asking one trusted person to help keep track of agreed follow-up. Privacy need not mean managing every concern alone.

When specialist treatment may be appropriate

Ask whether your needs can be managed by the current team or require addiction medicine, psychiatry, pain care or another specialist. Where mental health and substance-use problems occur together, both should be considered in the treatment plan. [4]

Residential care is one possible setting, not the default conclusion from taking a dependence-forming medicine. Ask what level of medical monitoring is required, what can be delivered locally and why any proposed admission is appropriate.

When comparing services, look beyond accommodation. Ask about prescribing responsibility, staffing outside office hours, emergency arrangements and continuity after discharge. A programme should explain the limits of what it can safely manage, including when a hospital or different specialist service is needed.

How a partner can help without policing

A helpful partner can support an appointment, share observations with consent and help with practical arrangements. They should not secretly alter doses, confiscate medication as a test or take over treatment decisions that belong with the patient and clinical team.

Agree on the role you actually want. For example: “Please come to the first appointment and help me remember the questions, but let me answer for myself.” Another person may prefer to attend alone and discuss the practical plan afterwards.

Supporters also need boundaries. They do not have to accept unsafe driving, threats or pressure to obtain medication. Where there are immediate safety concerns, seek professional help rather than turning the household into an improvised treatment unit.

Make continuity practical before the next change

Think ahead to weekends, travel, changes of address or a prescriber’s absence. Ask the clinical team how repeat prescriptions, reviews and unexpected supply problems should be handled. Keep the relevant contact information with your medication list rather than relying on the assumption that someone will be available when you need them.

If you are moving between services, request clarity about which clinician has accepted responsibility and from what date. A referral sent is not necessarily the same as an appointment arranged. Confirm the handover without independently altering treatment while the administrative details are unresolved.

You can also ask for a short written explanation of the current plan to share with another treating professional when appropriate. The aim is continuity of care, not obtaining additional prescriptions from disconnected sources. Tell each clinician about the others involved so that the plan remains visible and coordinated.

Know what requires urgent action

A suspected overdose, severe breathing difficulty, collapse, seizure or inability to wake someone is an emergency. Contact local emergency services and follow their instructions. Do not assume that a prescription makes these symptoms less serious. [1]

If you feel at risk of harming yourself or cannot stay safe, use urgent local support rather than waiting for a routine review. If the concern is worsening symptoms or interrupted medication without immediate danger, seek prompt medical advice and explain the medicine involved.

The constructive next step is a coordinated review: what you take, what it helps, what has changed and how to move forward safely. Needing that review is not a failure of character. It is a reason to bring the full picture into care.

Sources and further reading

  1. FDA: Benzodiazepine dependence and withdrawal safety
  2. CDC: Continuing Opioid Therapy
  3. NIMH: Tips for Talking With a Health Care Provider About Your Mental Health
  4. NIMH: Substance Use and Co-Occurring Mental Disorders

Sources consulted for this draft on 21 September 2026. Source publication dates vary. Reflection prompts are editorial suggestions, not validated diagnostic tools. Source organisations do not endorse this website or the programmes described here.